A new 3D model is developed to simulate the tumour microenvironment of a type of lymphoma
Researchers at the Clínic-IDIBAPS coordinated a study published in Blood Cancer Journal in which a new 3D system was developed from patient samples...
News from Institute of Cancer and Blood Diseases
Biomarkers of response to CAR T-cell therapy with ARI-0002h in refractory multiple myeloma are described
A study published recently in the journal Clinical Cancer Research identified biomarkers that can predict the response to CAR T-cell therapy target...
BBVA Foundation – Hospital Clínic Barcelona Joan Rodés – Josep Baselga Advanced Research Contracts Awarded
The BBVA Foundation – Hospital Clínic de Barcelona Advanced Research Contracts are aimed at specialists in the Health Sciences, with experience in...
Launch of the “Girem Full!" (“Turn the Page!”) campaign to help cancer research by encouraging reading
The goal of the current campaign is to reach 1,000 hours of cancer research. For each book read, 10 minutes of research, and for every six books, o...
Premiere of the documentary 'ARI, a story of love and life', about how the CAR-T became a reality at the Clínic
The Hospital Clínic Barcelona has presented the documentary ARI. "A story of love and lif", which tells the story of Ariana Benedé, Ari, and how a...
Presentation of the first model to predict response to CAR T-cell therapy in multiple myeloma
An international team, co-led by the Hospital Clínic-IDIBAPS, has identified four biomarkers that determine the risk of the recurrence of this canc...
The Hospital Clínic offers hair cryotherapy in some types of cancer to prevent hair loss
Cryotherapy consists of cooling the scalp and avoiding one of the most visible side effects of chemotherapy.
8 things you didn't know about lymphoma
There are still many questions surrounding lymphoma, its differences with leukemia and, above all, its treatment.
The ”la Caixa” Foundation and the Hospital Clínic Barcelona renew their cancer research alliance
The ”la Caixa” Foundation will allocate 4.6 million euros to promoting research at the Hospital Clínic Barcelona, in order to develop new, personal...
The CAR T-cell therapy from the Hospital Clínic-IDIBAPS for multiple myeloma is effective in patients with refractory disease
A multicentre study led by the Hospital Clínic Barcelona-IDIBAPS demonstrates the efficacy of the CAR T-cell therapy ARI0002h in treating patients...